Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study
- Author:
Yan XIAO
1
;
Huijun CHENG
;
Li WANG
;
Xiao YU
Author Information
- Publication Type:Original Article
- Keywords: Cervix Neoplasms; Apatinib Mesylate; Molecular Targeted Therapy; Drug Toxicity
- MeSH: Adenocarcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Fatigue; Follow-Up Studies; Hand-Foot Syndrome; Hemorrhage; Humans; Hypertension; Leukopenia; Molecular Targeted Therapy; Neutropenia; Proteinuria; Radiotherapy; Retrospective Studies; Uterine Cervical Neoplasms
- From:Journal of Gynecologic Oncology 2020;31(1):2-
- CountryRepublic of Korea
- Language:English
- Abstract:
